Market Overview:
The global parenteral drugs glass packaging market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for parenteral drugs and rising number of product approvals by regulatory authorities. In addition, the growing focus on patient safety is also driving the demand for parenteral drugs glass packaging. On the basis of type, PVC accounted for a major share of the global market in 2017. This can be attributed to its properties such as clarity, chemical resistance, and low cost.
Product Definition:
Parenteral drugs are those that are administered to a patient through an injection or infusion, as opposed to being taken orally. The term "parenteral" is derived from the Latin word parens, meaning "parent," and terra, meaning "earth." This refers to the fact that these drugs bypass the gastrointestinal tract and enter directly into the bloodstream.
Polyvinyl Chloride (PVC):
Polyvinyl Chloride (PVC) is a thermoplastic polymer, which can be processed through various manufacturing techniques including injection molding, extrusion and blow molding. It has the ability to withstand high temperatures and thus finds application in sterilization of medical devices as well as food packaging.
Polyolefin:
Polyolefin is a polymer, which contains olefins and is manufactured by the polymerization of ethylene. The most common types of polyolefin are High-Density Polyethylene (HDPE) and Low-Density Polyethylene (LDPE). They have different properties such as HDPE has more resistance to hydrocarbons whereas LDPE has better clarity for intravenous drugs.
Application Insights:
Based on application, the global Parenteral Drugs Glass Packaging market is segmented into large volume parenteral (LVP) and small volume parenteral (SVP). LVP held a larger share in 2017 owing to factors such as high product demand from healthcare professionals and anesthetists. Svp is anticipated to grow at a higher rate during the forecast period due to increasing awareness among patients regarding drug safety. Moreover, growing incidences of sepsis are expected to drive the segment growth over the forecast period.
An increase in incidence of chronic diseases such as cancer and diabetes has increased demand for long-acting injections which are used for multiple daily doses.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high healthcare expenditure, technological advancements, and presence of major players in this region. Moreover, increasing incidence of chronic diseases requiring long-term treatment with parenteral drugs is also one of the factors responsible for regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising geriatric population and awareness about advanced glass packaging among manufacturers operating in this region. In addition, economic development coupled with improvement in healthcare infrastructure will boost industry expansion over next eight years as well as it provides better access & services for patients thereby promoting competition among suppliers & manufacturers which ultimately benefits consumers by reducing product prices & enhancing quality products & services offered by companies within a country as well as from other countries through international trade channels such as e-commerce websites or foreign direct investment (FDI).
Growth Factors:
- Increasing demand for parenteral drugs from the emerging countries
- Technological advancements in parenteral drug packaging
- Growth in the number of biologics and specialty drugs
- Rising incidence of chronic diseases
- Stringent regulatory framework for drug safety
Scope Of The Report
Report Attributes
Report Details
Report Title
Parenteral Drugs Glass Packaging Market Research Report
By Type
Polyvinyl Chloride (PVC), Polyolefin
By Application
Large Volume Parenteral (LVP), Small Volume Parenteral (SVP)
By Companies
Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc, West Pharmaceutical Services, Terumo Corporation, Berry Plastics Corporation, Owens-Illinois, RPC Group, Graphic Packaging Group
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Parenteral Drugs Glass Packaging Market Report Segments:
The global Parenteral Drugs Glass Packaging market is segmented on the basis of:
Types
Polyvinyl Chloride (PVC), Polyolefin
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Large Volume Parenteral (LVP), Small Volume Parenteral (SVP)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ypsomed Holding AG
- Gerresheimer AG
- SiO2 Medical Products
- Schott AG
- Ompi Stevanato Group
- Becton Dickinson and Company
- MeadWestvaco Corporation
- Unilife Corporation Inc
- West Pharmaceutical Services
- Terumo Corporation
- Berry Plastics Corporation
- Owens-Illinois
- RPC Group
- Graphic Packaging Group
Highlights of The Parenteral Drugs Glass Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polyvinyl Chloride (PVC)
- Polyolefin
- By Application:
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Parenteral Drugs Glass Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Parenteral drugs are packaged in glass or plastic containers. Glass is the most common type of packaging, but other materials, such as aluminum foil and plastic wrap, are also used.
Some of the major players in the parenteral drugs glass packaging market are Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc, West Pharmaceutical Services, Terumo Corporation, Berry Plastics Corporation, Owens-Illinois, RPC Group, Graphic Packaging Group.
The parenteral drugs glass packaging market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Parenteral Drugs Glass Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Parenteral Drugs Glass Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Parenteral Drugs Glass Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Parenteral Drugs Glass Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Parenteral Drugs Glass Packaging Market Size & Forecast, 2018-2028
4.5.1 Parenteral Drugs Glass Packaging Market Size and Y-o-Y Growth
4.5.2 Parenteral Drugs Glass Packaging Market Absolute $ Opportunity
Chapter 5 Global Parenteral Drugs Glass Packaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Parenteral Drugs Glass Packaging Market Size Forecast by Type
5.2.1 Polyvinyl Chloride (PVC)
5.2.2 Polyolefin
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Parenteral Drugs Glass Packaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Parenteral Drugs Glass Packaging Market Size Forecast by Applications
6.2.1 Large Volume Parenteral (LVP)
6.2.2 Small Volume Parenteral (SVP)
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Parenteral Drugs Glass Packaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Parenteral Drugs Glass Packaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Parenteral Drugs Glass Packaging Analysis and Forecast
9.1 Introduction
9.2 North America Parenteral Drugs Glass Packaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Parenteral Drugs Glass Packaging Market Size Forecast by Type
9.6.1 Polyvinyl Chloride (PVC)
9.6.2 Polyolefin
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Parenteral Drugs Glass Packaging Market Size Forecast by Applications
9.10.1 Large Volume Parenteral (LVP)
9.10.2 Small Volume Parenteral (SVP)
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Parenteral Drugs Glass Packaging Analysis and Forecast
10.1 Introduction
10.2 Europe Parenteral Drugs Glass Packaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Parenteral Drugs Glass Packaging Market Size Forecast by Type
10.6.1 Polyvinyl Chloride (PVC)
10.6.2 Polyolefin
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Parenteral Drugs Glass Packaging Market Size Forecast by Applications
10.10.1 Large Volume Parenteral (LVP)
10.10.2 Small Volume Parenteral (SVP)
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Parenteral Drugs Glass Packaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Parenteral Drugs Glass Packaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Parenteral Drugs Glass Packaging Market Size Forecast by Type
11.6.1 Polyvinyl Chloride (PVC)
11.6.2 Polyolefin
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Parenteral Drugs Glass Packaging Market Size Forecast by Applications
11.10.1 Large Volume Parenteral (LVP)
11.10.2 Small Volume Parenteral (SVP)
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Parenteral Drugs Glass Packaging Analysis and Forecast
12.1 Introduction
12.2 Latin America Parenteral Drugs Glass Packaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Parenteral Drugs Glass Packaging Market Size Forecast by Type
12.6.1 Polyvinyl Chloride (PVC)
12.6.2 Polyolefin
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Parenteral Drugs Glass Packaging Market Size Forecast by Applications
12.10.1 Large Volume Parenteral (LVP)
12.10.2 Small Volume Parenteral (SVP)
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Parenteral Drugs Glass Packaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Parenteral Drugs Glass Packaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Parenteral Drugs Glass Packaging Market Size Forecast by Type
13.6.1 Polyvinyl Chloride (PVC)
13.6.2 Polyolefin
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Parenteral Drugs Glass Packaging Market Size Forecast by Applications
13.10.1 Large Volume Parenteral (LVP)
13.10.2 Small Volume Parenteral (SVP)
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Parenteral Drugs Glass Packaging Market: Competitive Dashboard
14.2 Global Parenteral Drugs Glass Packaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Ypsomed Holding AG
14.3.2 Gerresheimer AG
14.3.3 SiO2 Medical Products
14.3.4 Schott AG
14.3.5 Ompi Stevanato Group
14.3.6 Becton Dickinson and Company
14.3.7 MeadWestvaco Corporation
14.3.8 Unilife Corporation Inc
14.3.9 West Pharmaceutical Services
14.3.10 Terumo Corporation
14.3.11 Berry Plastics Corporation
14.3.12 Owens-Illinois
14.3.13 RPC Group
14.3.14 Graphic Packaging Group
